Correlation Between NOVO NORDISK and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NOVO NORDISK and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NOVO NORDISK and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NOVO NORDISK AS and Immunoprecise Antibodies, you can compare the effects of market volatilities on NOVO NORDISK and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NOVO NORDISK with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of NOVO NORDISK and Immunoprecise Antibodies.

Diversification Opportunities for NOVO NORDISK and Immunoprecise Antibodies

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between NONOF and Immunoprecise is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding NOVO NORDISK AS and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and NOVO NORDISK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NOVO NORDISK AS are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of NOVO NORDISK i.e., NOVO NORDISK and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between NOVO NORDISK and Immunoprecise Antibodies

Assuming the 90 days horizon NOVO NORDISK AS is expected to generate 0.44 times more return on investment than Immunoprecise Antibodies. However, NOVO NORDISK AS is 2.27 times less risky than Immunoprecise Antibodies. It trades about 0.0 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.36 per unit of risk. If you would invest  10,986  in NOVO NORDISK AS on March 29, 2022 and sell it today you would lose (36.00)  from holding NOVO NORDISK AS or give up 0.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

NOVO NORDISK AS  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
NOVO NORDISK AS 
NONOF Performance
0 of 100
Over the last 90 days NOVO NORDISK AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, NOVO NORDISK is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

NONOF Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Immunoprecise Antibodies is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Structure and Payout Changes

Last Split Factor
1:5
Dividend Date
2020-11-23
Last Split Date
2020-11-23

Immunoprecise Price Channel

NOVO NORDISK and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with NOVO NORDISK and Immunoprecise Antibodies

The main advantage of trading using opposite NOVO NORDISK and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NOVO NORDISK position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.

NOVO NORDISK AS

Pair trading matchups for NOVO NORDISK

Cincinnati Financial vs. NOVO NORDISK
Northrop Grumman vs. NOVO NORDISK
Chevron Corp vs. NOVO NORDISK
Macroaxis vs. NOVO NORDISK
Verizon Communications vs. NOVO NORDISK
Teucrium Corn vs. NOVO NORDISK
Home Depot vs. NOVO NORDISK
Micron Technology vs. NOVO NORDISK
Conagra Brands vs. NOVO NORDISK
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against NOVO NORDISK as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. NOVO NORDISK's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, NOVO NORDISK's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to NOVO NORDISK AS.
The idea behind NOVO NORDISK AS and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Northrop Grumman vs. Immunoprecise Antibodies
Chevron Corp vs. Immunoprecise Antibodies
Teucrium Corn vs. Immunoprecise Antibodies
Verizon Communications vs. Immunoprecise Antibodies
Cincinnati Financial vs. Immunoprecise Antibodies
Merck vs. Immunoprecise Antibodies
Conagra Brands vs. Immunoprecise Antibodies
Home Depot vs. Immunoprecise Antibodies
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunoprecise Antibodies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunoprecise Antibodies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunoprecise Antibodies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunoprecise Antibodies.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go